Clinical Outcomes of Knee Replacement
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The objective of this study is to document the demographic and clinical characteristics and the long-term clinical outcomes of patients who require a total knee arthroplasty (TKA).
The hypothesis is that MAKO® robot assisted surgery replacing one or two compartments of the knee joint has 10 year implant survival and clinical outcomes that are equivalent to other knee replacement systems.
| Condition | Intervention |
|---|---|
|
Total Knee Arthroplasty |
Procedure: Non-MAKO® Robot Assisted Total Knee Arthroplasty Procedure: MAKO® Robot Assisted Medial Knee Arthroplasty Procedure: MAKO® Robot Assisted Medial and PF Knee Arthroplasty Device: RESTORIS Multicompartmental Knee System Device: Depuy Knee Replacement System Device: Stryker® Knee Replacement System |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Clinical Outcomes of Joint Arthroplasty |
- Survivorship of Components [ Time Frame: 10 years ] [ Designated as safety issue: No ]Survivorship of components is defined as knee implant device(s) remaining in patient.
- American Knee Society Knee Score [ Time Frame: 1-2 weeks prior to surgery, 1-2 weeks after surgery, 4-6 weeks after surgery, 10-12 weeks after surgery, 6 months after surgery, 1 year, 2 years, 5 years, and 10 years after surgery ] [ Designated as safety issue: No ]The American Knee Society Score is an assessment and questionnaire that provides a rating of the pain, function, range of motion, and knee joint stability. It is subdivided into a knee score that rates only the knee joint itself and a functional score that rates the patient's ability to walk and climb stairs.
- Reduced WOMAC [ Time Frame: 1-2 weeks prior to surgery, 1-2 weeks after surgery, 4-6 weeks after surgery, 10-12 weeks after surgery, 6 months after surgery, 1 year, 2 years, 5 years, and 10 years after surgery ] [ Designated as safety issue: No ]The Reduced WOMAC is a truncated version of the Western Ontario and McMaster's University Osteoarthritis Index. The questionnaire is designed to assess pain, disability and joint stiffness in the osteoarthritis patient.
- Knee injury and Osteoarthritis Outcome Score [ Time Frame: 1-2 weeks prior to surgery, 1-2 weeks after surgery, 4-6 weeks after surgery, 10-12 weeks after surgery, 6 months after surgery, 1 year, 2 years, 5 years, and 10 years after surgery ] [ Designated as safety issue: No ]The KOOS or Knee injury and Osteoarthritis Outcome Score are patient completed questionnaires which assess the patient's opinion regarding their knee and its associated osteoarthritis.
- EQ-5D [ Time Frame: 1-2 weeks prior to surgery, 1-2 weeks after surgery, 4-6 weeks after surgery, 10-12 weeks after surgery, 6 months after surgery, 1 year, 2 years, 5 years, and 10 years after surgery ] [ Designated as safety issue: No ]The EQ-5D is a standardized instrument for use as a measure of health outcome.
- Forgotten Joint Score [ Time Frame: 1-2 weeks prior to surgery, 1-2 weeks after surgery, 4-6 weeks after surgery, 10-12 weeks after surgery, 6 months after surgery, 1 year, 2 years, 5 years, and 10 years after surgery ] [ Designated as safety issue: No ]The Forgotten Joint Score is a 12-item questionnaire completed by the patient to determine how aware they are of their joint in their everyday life.
| Estimated Enrollment: | 150 |
| Study Start Date: | October 2012 |
| Estimated Study Completion Date: | October 2025 |
| Estimated Primary Completion Date: | October 2025 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Knee Arthroplasty
Patients undergoing total knee arthroplasty. This may be Non-MAKO® Robot Assisted Total Knee Arthroplasty or MAKO® Robot Assisted Medial Knee Arthroplasty or MAKO® Robot Assisted Medial and PF Knee Arthroplasty The Non-MAKO® Robot Assisted Total Knee Arthroplasty uses the Depuy Knee Replacement System or the Stryker® Knee Replacement System. The MAKO® Robot Assisted Arthroplasty uses the RESTORIS Multicompartmental Knee System . |
Procedure: Non-MAKO® Robot Assisted Total Knee Arthroplasty
Patients undergoing a non-MAKO® robot assisted surgery to replace one or more compartments of the knee.
Other Names:
Procedure: MAKO® Robot Assisted Medial Knee Arthroplasty
Patients undergoing a MAKO® robot assisted surgery to replace the medial compartment of the knee.
Other Name: Unicompartmental Knee Arthroplasty (UKA)
Procedure: MAKO® Robot Assisted Medial and PF Knee Arthroplasty
Patients undergoing a MAKO® robot assisted surgery to replace the medial and patellofemoral (PF) compartments of the knee
Other Name: Bi-compartmental Knee Arthroplasty
Device: RESTORIS Multicompartmental Knee System
The RESTORIS Multicompartmental Knee (MCK) System components are intended for single or multicompartmental knee replacement used in conjunction with the MAKO® Robotic Arm Interactive Orthopedic System (RIO®). The components can be used for medial compartment, lateral compartment, patellofemoral compartment, or bicompartmental (medial and patellofemoral compartments) knee replacement. The device is intended to be used with bone cement.
Other Names:
Device: Depuy Knee Replacement System
The Depuy Knee Replacement System components are intended for use in total knee replacement. These components are intended for implantation with bone cement.
Device: Stryker® Knee Replacement System
The Stryker® Knee Replacement System components are intended for use in total knee replacement. These components are intended for implantation with bone cement.
|
Eligibility| Ages Eligible for Study: | 21 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
All male and non-pregnant females undergoing knee replacement
Inclusion Criteria:
- requires either primary or revision knee replacement surgery because of pain and joint stiffness that interferes with performance of normal daily activities
- has failed non-operative management of their joint disease
Exclusion Criteria:
- cognitively unable to complete study health-related quality of life forms
- pregnant women
Contacts and Locations| Contact: Pam Fairchild | 360-449-8728 | pfairchild@reboundmd.com |
| Contact: Mike Baer, MSPT | 360-449-8700 | mbaer@reboundmd.com |
| United States, Washington | |
| Rebound Orthopedics and Neurosurgery | Recruiting |
| Vancouver, Washington, United States, 98686 | |
| Contact: Pam Fairchild 360-449-8728 pfairchild@reboundmd.com | |
| Contact: Mike Baer, MSPT 360-449-8700 mbaer@reboundmd.com | |
| Principal Investigator: Todd Borus, MD | |
| Principal Investigator: Donald Roberts, MD | |
| Principal Investigator: | Todd Borus, MD | Northwest Surgical Specialists / Rebound Orthopedics and Neurosurgery |
| Principal Investigator: | Donald Roberts, MD | Northwest Surgical Specialists / Rebound Orthopedics and Neurosurgery |
More Information
No publications provided
| Responsible Party: | Northwest Surgical Specialists, Vancouver |
| ClinicalTrials.gov Identifier: | NCT01705366 History of Changes |
| Other Study ID Numbers: | MAKO-01 |
| Study First Received: | October 9, 2012 |
| Last Updated: | April 11, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Northwest Surgical Specialists, Vancouver:
|
Osteoarthritis Joint Disease Arthritis Musculoskeletal Disease |
ClinicalTrials.gov processed this record on June 13, 2013